Skip to main content
OpenTrials

Clinical trial condition

Biliary Tract Cancer (BTC)

Explore clinical trials studying Biliary Tract Cancer (BTC). Study availability and eligibility vary by location and protocol.

23 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Biliary Tract Cancer (BTC) trial results

Recruiting

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

NCT06622057

Conditions
Adenocarcinoma, Biliary Tract Cancer (BTC), Biliary Tract Diseases, +9 more
Locations
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • University Hospital Cleveland Medical Center Cleveland, Ohio, United States
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • The University of Arizona Cancer Center Tucson, Arizona, United States
View Trial Details
Recruiting

Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors

NCT07726446

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations
  • Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

NCT05482893

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +6 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sarah Cannon Research Institute (SCRI) Denver, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Recruiting

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

NCT07265674

Conditions
Adenocarcinoma, Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC), +12 more
Locations
  • City of Hope (Site 107) Duarte, California, United States
  • University of California at Irvine (Site 101) Orange, California, United States
  • UCLA Medical Center (Site 117) Santa Monica, California, United States
  • Moffitt Cancer Center Magnolia Campus (Site 123) Tampa, Florida, United States
View all 18 locations
View Trial Details
Recruiting

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

NCT07197554

Conditions
Adenocarcinoma, Advanced Solid Tumors, Biliary Tract Cancer (BTC), +30 more
Locations
  • The City of Hope National Medical Center Duarte, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • Mass General Brigham Cancer Institute Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

NCT07038343

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +34 more
Locations
  • Avenzo Therapeutics Recruiting Site Gilbert, Arizona, United States
  • Avenzo Therapeutics Recruiting Site Los Angeles, California, United States
  • Avenzo Therapeutics Recruiting Site Denver, Colorado, United States
  • Avenzo Therapeutics Recruiting Site New Haven, Connecticut, United States
View all 18 locations
View Trial Details
Recruiting

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

NCT04900818

Conditions
Adenocarcinoma Of Esophagus, Advanced Cancer, Biliary Tract Cancer (BTC), +20 more
Locations
  • Stern Center for Cancer Clinical Trials and Research Orange, California, United States
  • UCHealth Cancer Care - Anschutz Medical Campus Aurora, Colorado, United States
  • Horizon Oncology Research, LLC. Layfayette, Indiana, United States
  • Mass General Hospital Boston, Massachusetts, United States
View all 21 locations
View Trial Details

Related conditions